Cerro Pacific Wealth Advisors LLC Purchases Shares of 1,567 Zoetis Inc. $ZTS

Cerro Pacific Wealth Advisors LLC purchased a new stake in Zoetis Inc. (NYSE:ZTS) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,567 shares of the company’s stock, valued at approximately $244,000.

Several other hedge funds also recently added to or reduced their stakes in the business. Lindbrook Capital LLC increased its holdings in Zoetis by 1.8% in the 1st quarter. Lindbrook Capital LLC now owns 3,715 shares of the company’s stock valued at $612,000 after purchasing an additional 65 shares during the last quarter. Scott & Selber Inc. boosted its position in Zoetis by 0.6% in the 2nd quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock valued at $1,817,000 after buying an additional 67 shares during the period. Secure Asset Management LLC boosted its position in Zoetis by 2.9% in the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock valued at $382,000 after buying an additional 68 shares during the period. Quotient Wealth Partners LLC boosted its position in Zoetis by 2.3% in the 1st quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company’s stock valued at $521,000 after buying an additional 72 shares during the period. Finally, Menard Financial Group LLC boosted its position in Zoetis by 3.8% in the 1st quarter. Menard Financial Group LLC now owns 2,032 shares of the company’s stock valued at $305,000 after buying an additional 75 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on ZTS. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Argus reissued a “buy” rating and issued a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Piper Sandler raised their price target on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, August 11th. Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Stifel Nicolaus cut shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price target for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $196.71.

Zoetis Price Performance

Zoetis stock opened at $141.05 on Monday. The stock has a market cap of $62.51 billion, a P/E ratio of 24.28, a price-to-earnings-growth ratio of 2.26 and a beta of 0.90. The company has a fifty day simple moving average of $149.24 and a 200-day simple moving average of $154.33. Zoetis Inc. has a 12-month low of $139.34 and a 12-month high of $196.55. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.